Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893215465> ?p ?o ?g. }
- W2893215465 abstract "Chronic hepatitis C virus (HCV) genotype (GT) 3 infection with advanced liver disease has emerged as a challenging to treat by direct-acting antivirals (DAAs), but the efficacy of DAAs in Chinese HCV-GT3 patients is rarely reported. This study aimed to analyze the efficacy of sofosbuvir (SOF)-based regimens in Chinese patients with HCV-GT3 and compensated liver disease. This was a registered retrospective study. All patients had completed at least 12 weeks SOF-based regimens therapy (with or without RBV), and were followed up for at least 24 weeks after therapy discontinuation. The primary endpoint was sustained virological response 24 weeks after end of therapy (SVR24). A total of 102 patients who completed at least 12 weeks therapy were finally included, with 57 in SOF + Daclatasvir (SOF + DCV), 24 in SOF + DCV + ribavirin (RBV) and 21 in SOF/Velpatasvir (SOF/VEL). The total SVR24 rate was achieved in 90.20% (92/102), with 85.96% (49/57) in SOF + DCV, 91.67% (22/24) in SOF + DCV + RBV and 100.00% (21/21) in SOF/VEL. Among 10 relapsed patients (8 in SOF + DCV and 2 in SOF + DCV + RBV), the short course (12 weeks) of therapy and no RBV addition may be the leading cause. In this cohort, the SVR24 rate was not statistically different between patients with and without cirrhosis (81.82% [27/33] vs. 94.20% [65/69], P = 0.073). Additionally, both FIB-4 (4.03 vs. 2.08, P < 0.001) and APRI (2.15 vs. 0.68, P < 0.001) scores were significant improved from baseline to week 24 after completion of therapy, regardless of the presence of cirrhosis. SOF-based regimens are highly effective in viral clearance and fibrosis remission for Chinese patients with HCV-GT3 infection. If available, SOF/VEL should be first considered." @default.
- W2893215465 created "2018-10-05" @default.
- W2893215465 creator A5006234538 @default.
- W2893215465 creator A5009073651 @default.
- W2893215465 creator A5011086107 @default.
- W2893215465 creator A5021862429 @default.
- W2893215465 creator A5026041577 @default.
- W2893215465 creator A5026222277 @default.
- W2893215465 creator A5033469589 @default.
- W2893215465 creator A5061992559 @default.
- W2893215465 date "2018-10-01" @default.
- W2893215465 modified "2023-10-17" @default.
- W2893215465 title "Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study" @default.
- W2893215465 cites W1604557454 @default.
- W2893215465 cites W1827623663 @default.
- W2893215465 cites W2035804055 @default.
- W2893215465 cites W2044203022 @default.
- W2893215465 cites W2078251659 @default.
- W2893215465 cites W2083200314 @default.
- W2893215465 cites W2150652264 @default.
- W2893215465 cites W2184462609 @default.
- W2893215465 cites W2185992051 @default.
- W2893215465 cites W2190613497 @default.
- W2893215465 cites W2282504480 @default.
- W2893215465 cites W2289667014 @default.
- W2893215465 cites W2342618707 @default.
- W2893215465 cites W2413062795 @default.
- W2893215465 cites W2471601387 @default.
- W2893215465 cites W2485475233 @default.
- W2893215465 cites W2578013986 @default.
- W2893215465 cites W2607038290 @default.
- W2893215465 cites W2739670275 @default.
- W2893215465 cites W2765384989 @default.
- W2893215465 cites W2768722273 @default.
- W2893215465 cites W2772439386 @default.
- W2893215465 cites W4211243282 @default.
- W2893215465 doi "https://doi.org/10.1186/s12985-018-1066-8" @default.
- W2893215465 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6167801" @default.
- W2893215465 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30285800" @default.
- W2893215465 hasPublicationYear "2018" @default.
- W2893215465 type Work @default.
- W2893215465 sameAs 2893215465 @default.
- W2893215465 citedByCount "17" @default.
- W2893215465 countsByYear W28932154652019 @default.
- W2893215465 countsByYear W28932154652020 @default.
- W2893215465 countsByYear W28932154652021 @default.
- W2893215465 countsByYear W28932154652023 @default.
- W2893215465 crossrefType "journal-article" @default.
- W2893215465 hasAuthorship W2893215465A5006234538 @default.
- W2893215465 hasAuthorship W2893215465A5009073651 @default.
- W2893215465 hasAuthorship W2893215465A5011086107 @default.
- W2893215465 hasAuthorship W2893215465A5021862429 @default.
- W2893215465 hasAuthorship W2893215465A5026041577 @default.
- W2893215465 hasAuthorship W2893215465A5026222277 @default.
- W2893215465 hasAuthorship W2893215465A5033469589 @default.
- W2893215465 hasAuthorship W2893215465A5061992559 @default.
- W2893215465 hasBestOaLocation W28932154651 @default.
- W2893215465 hasConcept C126322002 @default.
- W2893215465 hasConcept C159047783 @default.
- W2893215465 hasConcept C203092338 @default.
- W2893215465 hasConcept C2522874641 @default.
- W2893215465 hasConcept C2776408679 @default.
- W2893215465 hasConcept C2776979040 @default.
- W2893215465 hasConcept C2777214474 @default.
- W2893215465 hasConcept C2778390639 @default.
- W2893215465 hasConcept C2778715236 @default.
- W2893215465 hasConcept C2780040827 @default.
- W2893215465 hasConcept C535046627 @default.
- W2893215465 hasConcept C71924100 @default.
- W2893215465 hasConcept C72563966 @default.
- W2893215465 hasConcept C90924648 @default.
- W2893215465 hasConceptScore W2893215465C126322002 @default.
- W2893215465 hasConceptScore W2893215465C159047783 @default.
- W2893215465 hasConceptScore W2893215465C203092338 @default.
- W2893215465 hasConceptScore W2893215465C2522874641 @default.
- W2893215465 hasConceptScore W2893215465C2776408679 @default.
- W2893215465 hasConceptScore W2893215465C2776979040 @default.
- W2893215465 hasConceptScore W2893215465C2777214474 @default.
- W2893215465 hasConceptScore W2893215465C2778390639 @default.
- W2893215465 hasConceptScore W2893215465C2778715236 @default.
- W2893215465 hasConceptScore W2893215465C2780040827 @default.
- W2893215465 hasConceptScore W2893215465C535046627 @default.
- W2893215465 hasConceptScore W2893215465C71924100 @default.
- W2893215465 hasConceptScore W2893215465C72563966 @default.
- W2893215465 hasConceptScore W2893215465C90924648 @default.
- W2893215465 hasIssue "1" @default.
- W2893215465 hasLocation W28932154651 @default.
- W2893215465 hasLocation W28932154652 @default.
- W2893215465 hasLocation W28932154653 @default.
- W2893215465 hasLocation W28932154654 @default.
- W2893215465 hasOpenAccess W2893215465 @default.
- W2893215465 hasPrimaryLocation W28932154651 @default.
- W2893215465 hasRelatedWork W2114705120 @default.
- W2893215465 hasRelatedWork W2460376027 @default.
- W2893215465 hasRelatedWork W2560876434 @default.
- W2893215465 hasRelatedWork W2793060991 @default.
- W2893215465 hasRelatedWork W2950271342 @default.
- W2893215465 hasRelatedWork W2981770118 @default.
- W2893215465 hasRelatedWork W2990662371 @default.
- W2893215465 hasRelatedWork W3031498534 @default.